StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research note issued on Wednesday. The firm set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Stock Performance
NYSE:CO opened at $1.50 on Wednesday. The stock’s 50-day moving average is $1.43 and its 200-day moving average is $1.35. Global Cord Blood has a 1-year low of $2.03 and a 1-year high of $5.50. The stock has a market cap of $182.33 million, a P/E ratio of 2.34 and a beta of 0.16.
About Global Cord Blood
Recommended Stories
- Five stocks we like better than Global Cord Blood
- What is MarketRankā¢? How to Use it
- 3 Leveraged ETFs to Multiply Returns
- Investing in Construction Stocks
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.